Waters Corporation Schedules First Quarter 2026 Earnings Conference Call
Waters Corporation (NYSE:WAT) will report Q1 2026 results and host a conference call on May 5, 2026 at 8:30 a.m. ET.
Rhea-AI Summary
Waters Corporation (NYSE:WAT) will report Q1 2026 results and host a conference call on May 5, 2026 at 8:30 a.m. ET.
A live webcast will be available on Waters Investor Relations, and a replay will remain available through at least June 2, 2026.
Positive
- None.
Negative
- None.
Details
News Market Reaction – WAT
On Apr 21, the first trading day after this news, WAT closed 0.11% below the previous close.
Data tracked by StockTitan Argus for the Apr 21 session.
Key Figures
- Earnings call date
- May 5, 2026
- Q1 2026 financial results conference call
- Call time
- 8:30 a.m. Eastern Time
- Scheduled start for Q1 2026 conference call
- Webcast replay end
- June 2, 2026 (midnight ET)
- Replay availability for earnings call webcast
- Employees
- ~16,000 colleagues
- Global Waters workforce cited in article
- Current price
- $327.77
- Pre-news market context for WAT
- Daily move
- 2.74%
- Price change over prior 24 hours before this news
- 52-week range
- $275.05–$414.15
- Low and high over the last 52 weeks
- Shares outstanding
- 98,101,871 shares
- As of February 19, 2026 per S-3ASR shelf filing
Previous Conferences,earnings Reports
-
Announced Q4 2025 results release date and conference call details.
-
Set timing and webcast info for Q3 2025 earnings conference call.
-
Outlined Q2 2025 earnings call date, time, and webcast replay window.
-
Announced Q1 2025 earnings call schedule and online access details.
-
Released schedule for Q4 2024 financial results conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
diagnostics medical
informatics technical
antibiotic resistance medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.
Caspar Tudor, Head of Investor Relations
investor_relations@waters.com
View original content:https://www.prnewswire.com/news-releases/waters-corporation-schedules-first-quarter-2026-earnings-conference-call-302747613.html
SOURCE Waters Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.